Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by sah1on Jun 25, 2018 2:06pm
245 Views
Post# 28225248

RE:RE:Meeting

RE:RE:Meeting SB I agree with most of what you say. The issue on cutting employees temporarily doesn't cut it with me. Laying people off costs money especially if you are just going to need them 9 months down the road. Moreover the plant has got to be working to demonstrate the new controls and to pass the FDA inspection. Also with Green Cross hiring, any laid off  employees will just skip across town.

I am looking forward to what Pritchard has to say on cash burn. Clearly, plasma sales, exercise of the fifth tranche of the LOC and perhaps some resin sales are going to pushed as far as possible. But I agree if a 4050 deal goes much beyond August a financing is likely required unless Thomvest agrees to altering the terms of the LOC.

no doubt with the Alstrom results Big Pharma is in the tent. I don' t doubt a deal will be closed it is only the timing that is in question. Hopefully the conference call will add colour to the negotiations being undertaken, cash burn and other elements of the financial framework outlined at the AGM.
Bullboard Posts